Painreform Ltd (PRFX) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $1.02 (+0.00%), Market cap $0.00B, 52-week low–high $0.60 ~ $3.46.
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Financial statements, price targets, institutional (13F) holdings and related news for Painreform Ltd are updated in real time on BlackAll Trade.
Painreform Ltd trades at $1.02 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Painreform Ltd has a market cap of about $0.00B.
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to th